4.8 Article

CDK1 structures reveal conserved and unique features of the essential cell cycle CDK

Journal

NATURE COMMUNICATIONS
Volume 6, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms7769

Keywords

-

Funding

  1. MRC [G0901526]
  2. Astex Pharmaceuticals
  3. Medical Research Council [G0901526] Funding Source: researchfish
  4. MRC [G0901526] Funding Source: UKRI

Ask authors/readers for more resources

CDK1 is the only essential cell cycle CDK in human cells and is required for successful completion of M-phase. It is the founding member of the CDK family and is conserved across all eukaryotes. Here we report the crystal structures of complexes of CDK1-Cks1 and CDK1cyclin B-Cks2. These structures confirm the conserved nature of the inactive monomeric CDK fold and its ability to be remodelled by cyclin binding. Relative to CDK2-cyclin A, CDK1-cyclin B is less thermally stable, has a smaller interfacial surface, is more susceptible to activation segment dephosphorylation and shows differences in the substrate sequence features that determine activity. Both CDK1 and CDK2 are potential cancer targets for which selective compounds are required. We also describe the first structure of CDK1 bound to a potent ATP-competitive inhibitor and identify aspects of CDK1 structure and plasticity that might be exploited to develop CDK1-selective inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor

Steven R. Whittaker, Clare Barlow, Mathew P. Martin, Caterina Mancusi, Steve Wagner, Annette Self, Elaine Barrie, Robert Te Poele, Swee Sharp, Nathan Brown, Stuart Wilson, Wayne Jackson, Peter M. Fischer, Paul A. Clarke, Michael I. Walton, Edward McDonald, Julian Blagg, Martin Noble, Michelle D. Garrett, Paul Workman

MOLECULAR ONCOLOGY (2018)

Article Chemistry, Organic

Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach

Duncan C. Miller, Mathew P. Martin, Santosh Adhikari, Alfie Brennan, Jane A. Endicott, Bernard T. Golding, Ian R. Hardcastle, Amy Heptinstall, Stephen Hobson, Claire Jennings, Lauren Molyneux, Yvonne Ng, Stephen R. Wedge, Martin E. M. Noble, Celine Cano

ORGANIC & BIOMOLECULAR CHEMISTRY (2018)

Article Biochemical Research Methods

CCP4i2: the new graphical user interface to the CCP4 program suite

Liz Potterton, Jon Agirre, Charles Ballard, Kevin Cowtan, Eleanor Dodson, Phil R. Evans, Huw T. Jenkins, Ronan Keegan, Eugene Krissinel, Kyle Stevenson, Andrey Lebedev, Stuart J. McNicholas, Robert A. Nicholls, Martin Noble, Navraj S. Pannu, Christian Roth, George Sheldrick, Pavol Skubak, Johan Turkenburg, Ville Uski, Frank von Delft, David Waterman, Keith Wilson, Martyn Winn, Marcin Wojdyr

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2018)

Article Chemistry, Multidisciplinary

Tuning the Binding Affinity and Selectivity of Perfluoroaryl-Stapled Peptides by Cysteine-Editing

Sanne J. M. Verhoork, Claire E. Jennings, Neshat Rozatian, Judith Reeks, Jieman Meng, Emily K. Corlett, Fazila Bunglawala, Martin E. M. Noble, Andrew G. Leach, Christopher R. Coxon

CHEMISTRY-A EUROPEAN JOURNAL (2019)

Review Biochemistry & Molecular Biology

Structural insights into the functional diversity of the CDK-cyclin family

Daniel J. Wood, Jane A. Endicott

OPEN BIOLOGY (2018)

Article Chemistry, Medicinal

FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation

Daniel J. Wood, J. Daniel Lopez-Fernandez, Leanne E. Knight, Islam Al-Khawaldeh, Conghao Gai, Shengying Lin, Mathew P. Martin, Duncan C. Miller, Celine Cano, Jane A. Endicott, Ian R. Hardcastle, Martin E. M. Noble, Michael J. Waring

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4

Stephanie M. Myers, Duncan C. Miller, Lauren Molyneux, Mercedes Arasta, Ruth H. Bawn, Timothy J. Blackburn, Simon J. Cook, Noel Edwards, Jane A. Endicott, Bernard T. Golding, Roger J. Griffin, Tim Hammonds, Ian R. Hardcastle, Suzannah J. Harnor, Amy B. Heptinstall, Pamela A. Lochhead, Mathew P. Martin, Nick C. Martin, David R. Newell, Paul J. Owen, Leon C. Pang, Tristan Reuillo, Laurent J. M. Rigoreau, Huw D. Thomas, Julie A. Tucker, Lan-Zhen Wang, Ai-Ching Wong, Martin E. M. Noble, Stephen R. Wedge, Celine Cano

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Letter Biochemical Research Methods

Announcing mandatory submission of PDBx/mmCIF format files for crystallographic depositions to the Protein Data Bank (PDB)

Paul D. Adams, Pavel V. Afonine, Kumaran Baskaran, Helen M. Berman, John Berrisford, Gerard Bricogne, David G. Brown, Stephen K. Burley, Minyu Chen, Zukang Feng, Claus Flensburg, Aleksandras Gutmanas, Jeffrey C. Hoch, Yasuyo Ikegawa, Yumiko Kengaku, Eugene Krissinel, Genji Kurisu, Yuhe Liang, Dorothee Liebschner, Lora Mak, John L. Markley, Nigel W. Moriarty, Garib N. Murshudov, Martin Noble, Ezra Peisach, Irina Persikova, Billy K. Poon, Oleg V. Sobolev, Eldon L. Ulrich, Sameer Velankar, Clemens Vonrhein, John Westbrook, Marcin Wojdyr, Masashi Yokochi, Jasmine Y. Young

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)

Article Multidisciplinary Sciences

Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors

Pamela A. Lochhead, Julie A. Tucker, Natalie J. Tatum, Jinhua Wang, David Oxley, Andrew M. Kidger, Victoria P. Johnson, Megan A. Cassidy, Nathanael S. Gray, Martin E. M. Noble, Simon J. Cook

NATURE COMMUNICATIONS (2020)

Article Biochemical Research Methods

Exiting the tunnel of uncertainty: crystal soak to validated hit

Mathew P. Martin, Martin E. M. Noble

Summary: This article evaluates methods for validating and prioritizing crystallographic fragment screening results. Through retrospective analysis of an ATAD2 screening campaign and other successful fragment screening projects, a "triangulation" approach is suggested to develop qualitative structure-activity relationships (SARs) as an alternative to on-scale biophysical, biochemical, and/or biological measurements.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition

Daniel J. Wood, Svitlana Korolchuk, Natalie J. Tatum, Lan-Zhen Wang, Jane A. Endicott, Martin E. M. Noble, Mathew P. Martin

CELL CHEMICAL BIOLOGY (2019)

No Data Available